-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – MG01-T517 in Allergic Asthma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MG01-T517 in Allergic Asthma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MG01-T517 in Allergic Asthma Drug Details: MG01-T517 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – MG01-T521 in Allergic Asthma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MG01-T521 in Allergic Asthma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MG01-T521 in Allergic Asthma Drug Details: MG01-T521 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – MV-130 in Urinary Tract Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MV-130 in Urinary Tract Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MV-130 in Urinary Tract Infections Drug Details: MV-130 (Bactek) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GNC-035 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GNC-035 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GNC-035 in Solid Tumor Drug Details: GNC-035 is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Romidepsin in Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Romidepsin in Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Romidepsin in Chronic Lymphocytic Leukemia (CLL) Drug Details: Romidepsin (Istodax)...
-
Product Insights
Rhino-Conjunctivitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Rhino-Conjunctivitis - Drugs In Development, 2023’, provides an overview of the Rhino-Conjunctivitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rhino-Conjunctivitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Allergic Rhino-Conjunctivitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Allergic Rhino-Conjunctivitis - Drugs In Development, 2023’, provides an overview of the Allergic Rhino-Conjunctivitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Allergic Rhino-Conjunctivitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Conjunctivitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Conjunctivitis - Drugs In Development, 2023’, provides an overview of the Conjunctivitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Conjunctivitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Allergic Asthma – Drugs In Development, 2023
Global Markets Direct’s, ‘Allergic Asthma - Drugs In Development, 2023’, provides an overview of the Allergic Asthma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Allergic Asthma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Allergic Rhinitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Allergic Rhinitis - Drugs In Development, 2023’, provides an overview of the Allergic Rhinitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Allergic Rhinitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...